Viemed Healthcare, Inc.
VMD- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- SEC CIK
- 0001729149
No open-market purchases or sales by Viemed Healthcare, Inc. insiders were filed in the last 90 days; 166 institutions reported holding it in 13F filings for Q2 2026, worth $291.2M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Viemed Healthcare, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 132
- +6 vs. Q3 2025
- Shares held
- 23.8M
- +384.7K (+1.6%) vs. Q3 2025
- Total value
- $177.0M
- +$17.8M (+11.2%) vs. Q3 2025
- New holders
- 20
- 43 more added
- Sold out
- 14
- 43 more reduced
5 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 166 | $291.2M |
| Q1 2026 | 150 | $229.2M |
| Q4 2025 | 132 | $177.0M |
| Q3 2025 | 131 | $166.2M |
| Q2 2025 | 127 | $175.5M |
| Q1 2025 | 139 | $180.9M |
| Q4 2024 | 141 | $201.7M |
| Q3 2024 | 121 | $185.5M |
| Q2 2024 | 116 | $166.5M |
| Q1 2024 | 112 | $233.4M |
| Q4 2023 | 104 | $181.9M |
| Q3 2023 | 112 | $158.7M |
| Q2 2023 | 103 | $246.4M |
| Q1 2023 | 89 | $217.5M |
| Q4 2022 | 81 | $152.3M |
| Q3 2022 | 65 | $110.0M |
| Q2 2022 | 76 | $104.5M |
| Q1 2022 | 89 | $109.4M |
| Q4 2021 | 89 | $116.8M |
| Q3 2021 | 83 | $119.1M |
| Q2 2021 | 77 | $161.1M |
| Q1 2021 | 100 | $214.2M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Viemed Healthcare, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BNP Paribas Arbitrage, SA | 121,184 | $900.4K | 0.00% | +23,093+23.5% | Added |
| SummerHaven Investment Management, LLC | 121,936 | $906.0K | 0.51% | 00.0% | Unchanged |
| Perritt Capital Management Inc | 130,100 | $966.6K | 1.62% | +5,000+4.0% | Added |
| Sentinus, LLC | 130,100 | $966.6K | 0.09% | +130,100 | New |
| Barclays PLC | 131,759 | $979.0K | 0.00% | +3,480+2.7% | Added |
| Gsa Capital Partners LLP | 142,449 | $1.06M | 0.09% | −24,244−14.5% | Reduced |
| JPMorgan Chase & Co | 154,841 | $1.15M | 0.00% | +4,921+3.3% | Added |
| Expect Equity LLC | 173,970 | $1.29M | 1.06% | +64,961+59.6% | Added |
| Dimensional Fund Advisors LP | 193,792 | $1.44M | 0.00% | −31,325−13.9% | Reduced |
| Rice Hall James & Associates, LLC | 230,382 | $1.71M | 0.09% | +30,981+15.5% | Added |
| Northern Trust Corp | 248,735 | $1.85M | 0.00% | −22,335−8.2% | Reduced |
| Qube Research & Technologies Ltd | 253,612 | $1.88M | 0.00% | −38,288−13.1% | Reduced |
| Two Sigma Investments, LP | 261,714 | $1.94M | 0.00% | +10,304+4.1% | Added |
| Penbrook Management LLC | 271,548 | $2.02M | 1.39% | −780−0.3% | Reduced |
| Segall Bryant & Hamill, LLC | 288,771 | $2.15M | 0.03% | −675−0.2% | Reduced |
| Morgan Stanley | 292,771 | $2.18M | 0.00% | +27,206+10.2% | Added |
| Bard Associates Inc | 339,344 | $2.52M | 0.65% | −1,653−0.5% | Reduced |
| Arrowstreet Capital, Limited Partnership | 352,323 | $2.62M | 0.00% | 00.0% | Unchanged |
| Raffles Associates LP | 417,691 | $3.10M | 2.33% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 440,800 | $3.28M | 0.01% | −6,200−1.4% | Reduced |
| Panagora Asset Management Inc | 468,740 | $3.48M | 0.01% | +34,811+8.0% | Added |
| Tocqueville Asset Management L.P. | 472,100 | $3.51M | 0.05% | +25,000+5.6% | Added |
| First Eagle Investment Management, LLC | 518,157 | $3.85M | 0.01% | +40,313+8.4% | Added |
| Punch & Associates Investment Management, Inc. | 671,360 | $4.99M | 0.29% | 00.0% | Unchanged |
| State Street Corp | 675,190 | $5.02M | 0.00% | +11,385+1.7% | Added |
| Geode Capital Management, LLC | 776,362 | $5.77M | 0.00% | −21,285−2.7% | Reduced |
| Ameriprise Financial Inc | 822,813 | $6.11M | 0.00% | +697,866+558.5% | Added |
| Nantahala Capital Management, LLC | 932,445 | $6.93M | 0.41% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 1,447,033 | $10.8M | 0.00% | +49,962+3.6% | Added |
| Vanguard Group Inc | 1,782,440 | $13.2M | 0.00% | −21,975−1.2% | Reduced |
| Forager Capital Management, LLC | 2,785,871 | $20.7M | 9.37% | +49,399+1.8% | Added |
| BlackRock, Inc. | 4,626,076 | $34.4M | 0.00% | −142,252−3.0% | Reduced |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −384,000−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −69,030−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −46,994−100.0% | Sold out |
| PharVision Advisers, LLC | 0 | $0 | 0.00% | −39,036−100.0% | Sold out |
| Boston Partners | 0 | $0 | 0.00% | −38,396−100.0% | Sold out |
| Oxford Asset Management LLP | 0 | $0 | 0.00% | −35,690−100.0% | Sold out |
| Petrus Trust Company, LTA | 0 | $0 | 0.00% | −21,436−100.0% | Sold out |
| Quarry LP | 0 | $0 | 0.00% | −7,129−100.0% | Sold out |
| Principal Securities, Inc. | 0 | $0 | 0.00% | −1,592−100.0% | Sold out |
| SRS Capital Advisors, Inc. | 0 | $0 | 0.00% | −861−100.0% | Sold out |
| Cornerstone Planning Group LLC | 0 | $0 | 0.00% | −175−100.0% | Sold out |
| Spire Wealth Management | 0 | $0 | 0.00% | −417−100.0% | Sold out |
| Clearstead Advisors, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| SBI Securities Co., Ltd. | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Kent Lake PR LLC | – | – | – | – | Not filed |
| Cove Street Capital, LLC | – | – | – | – | Not filed |
| AMH Equity Ltd | – | – | – | – | Not filed |
| Cubist Systematic Strategies, LLC | – | – | – | – | Not filed |
| Point72 (DIFC) Ltd | – | – | – | – | Not filed |